about
Dovitinib: rationale, preclinical and early clinical data in urothelial carcinoma of the bladder.Huachansu suppresses human bladder cancer cell growth through the Fas/Fasl and TNF- alpha/TNFR1 pathway in vitro and in vivoToward personalized management in bladder cancer: the promise of novel molecular taxonomy.Tubeimoside-1 (TBMS1) inhibits lung cancer cell growth and induces cells apoptosis through activation of MAPK-JNK pathway.
P2860
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
Emerging drugs for urothelial carcinoma.
@en
type
label
Emerging drugs for urothelial carcinoma.
@en
prefLabel
Emerging drugs for urothelial carcinoma.
@en
P2860
P1476
Emerging drugs for urothelial carcinoma.
@en
P2093
Benjamin A Gartrell
Guru Sonpavde
P2860
P304
P356
10.1517/14728214.2013.853741
P407
P577
2013-11-06T00:00:00Z